Home > Innovations in Regulatory Science Awards Gala

Innovations in Regulatory Science Awards Gala

Join the Foundation in honoring advances in regulatory science, and two people who make them happen. On December 5th, 2017, from 6:00pm to 9:00pm, at the Kaiser Permanente Center for Total Health, we're hosting the first-ever awards gala for innovations in this field. Why? Because behind every breakthrough in public health are regulators, scientists and policy makers dedicated to safety, efficacy and accountability. The winner of the inaugural Leadership Award goes to Dr. Janet Woodcock and the Healthcare Innovations Award goes to Dr. Patrick Ryan.

In Dr. Woodcock, the Leadership Award recognizes lifetime contributions and service to the field of regulatory science and public health. Woodcock is the Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration with 30 years of leadership transforming the agency into the premier regulator of pharmaceuticals and biologics in the world. Advances in regulatory science under her watch include pharmaceutical manufacturing, pharmacogenomics in drug development, the "Critical Path" Initiative, drug safety management, streamlined review processes and data standardization.

Patrick Ryan's win for Healthcare Innovation recognizes his influence in the development of regulatory policy to improve public health. Ryan is the Senior Director and Head of Epidemiology Analytics at Janssen Research & Development, focusing on the Observational Medical Outcomes Partnership (OMOP) and Observational Health Data Sciences and Informatics (OHDSI) Network. His award also reflects his contributions to advancement in the analytical framework using the Common Data Model (CDM) in the Janssen R&D organization and beyond. Both honorees will accept their awards in person at the gala.

Attending the first-ever Innovations in Regulatory Science Awards Gala is a chance to show your support for the science, and to meet leaders from FDA, industry, advocacy and nonprofits working to improve public health. There are individual tickets available for purchase via credit card (see top of page) or click here for payment information to pay by check. If your organization would like to sponsor the gala or purchase tables for the event, please contact the Foundation's Director of Development, Torrey Shallcross at (202) 849-2070 or email tshallcross@reaganudall.org. Join us in celebrating the public-private partnerships that modernize regulatory science.

Of course, the gala would not be possible without generous support from a wide range of sponsors.

The flagship, Presenting Sponsor for the inaugural, Reagan-Udall Foundation for the FDA's Innovations in Regulatory Science Awards Gala is:

Gala sponsors at the Innovations level are:

The gala's sponsors at the Regulatory level are:

 

 

And the sponsorship suite would not be complete without the support of VIP contributors:

 

 

The Reagan-Udall Foundation for the FDA would like to thank the following committee members for their work in launching the Innovations in Regulatory Science Awards Gala. One of the most difficult responsibilities of an awards gala is narrowing the field of nominees to arrive at only two winners. Our distinguished award committee members are:

 

Robert Califf, M.D. -- 22nd Commissioner of the FDA

Garry Neil, M.D. -- Chief Scientific Officer, Aevi Genomic Medicine

Richard Schilsky, M.D. -- Senior Vice President and Chief Medical Officer, ASCO

William Sellars, M.D. -- Core Faculty Member, Broad Institute, Dana-Farber Cancer Institute and Harvard Medical School

Robert Temple, M.D. -- Deputy Center Director for Clinical Science, CDER and Acting Deputy Director of the Office of Drug Evaluation

 

The Gala would not be possible without the behind-the-scenes work of a talented and diverse host committee, representing a cross section of the regulatory science field. These members are:

 

Louis DeGennaro, Ph.D. -- President and CEO, Leukemia and Lymphoma Society

Richard Gaynor, M.D. -- President of Research and Development, Neon Therapeutics

Julie Hambleton, M.D. -- Strategic Consultant, former Vice President and Head of U.S. Medical Affairs, Bristol-Meyers Squibb

Margaret Hamburg, M.D. -- 21st Commissioner of the FDA

Lynn Matrisian, Ph.D. -- Chief Science Officer, Pancreatic Cancer Action Network